Literature DB >> 10501432

Marked and sustained improvement 2 years after autologous stem cell transplantation in a girl with systemic sclerosis.

A Martini1, R Maccario, A Ravelli, D Montagna, F De Benedetti, F Bonetti, S Viola, M Zecca, C Perotti, F Locatelli.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10501432     DOI： 10.1093/rheumatology/38.8.773

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

Review 1.  Bone marrow transplantation in the treatment of systemic sclerosis.

Authors:  F Viganego; R Nash; D E Furst
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

2.  High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.

Authors:  Peter A McSweeney; Richard A Nash; Keith M Sullivan; Jan Storek; Leslie J Crofford; Roger Dansey; Maureen D Mayes; Kevin T McDonagh; J Lee Nelson; Theodore A Gooley; Leona A Holmberg; C S Chen; Mark H Wener; Katherine Ryan; Julie Sunderhaus; Ken Russell; John Rambharose; Rainer Storb; Daniel E Furst
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

Review 3.  [Scleroderma in childhood and adolescence. New aspects on classification, etiology and therapy].

Authors:  H J Girschick
Journal:  Z Rheumatol       Date:  2008-03       Impact factor: 1.372

Review 4.  Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease.

Authors:  N M Wulffraat; L A Sanders; W Kuis
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.686
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.